atracurium has been researched along with Chronic Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arvieux, CC; Gioux, M; Giroux-Metges, MA; Gueret, G; Morel, J; Pennec, JP; Rannou, F; Rossignol, B; Talarmin, H | 1 |
| Barohn, RJ; Jackson, CE; McVey, AL; Ridings, LW; Rogers, SJ | 1 |
| Ward, S; Weatherley, BC | 1 |
3 other study(ies) available for atracurium and Chronic Disease
| Article | Year |
|---|---|
Effects of chronic sepsis on contractile properties of fast twitch muscle in an experimental model of critical illness neuromyopathy in the rat.
Topics: Animals; Atracurium; Chronic Disease; Disease Models, Animal; Female; Gene Expression; Muscle Contraction; Muscle Fibers, Fast-Twitch; Muscle Strength; Muscle Weakness; Polyneuropathies; Rats; Rats, Wistar; Receptors, Cholinergic; RNA, Messenger; Ryanodine Receptor Calcium Release Channel; Systemic Inflammatory Response Syndrome | 2008 |
Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids.
Topics: Adrenal Cortex Hormones; Adult; Atracurium; Chronic Disease; Female; Humans; Male; Microscopy, Electron; Middle Aged; Muscles; Neuromuscular Nondepolarizing Agents; Pancuronium; Paralysis; Vecuronium Bromide | 1994 |
Pharmacokinetics of atracurium and its metabolites.
Topics: Atracurium; Chronic Disease; Half-Life; Humans; Isoquinolines; Kidney Failure, Chronic; Kinetics; Liver Diseases; Metabolic Clearance Rate; Neuromuscular Blocking Agents | 1986 |